NEFL and Parkinson disease: In addition, plasma NF-L was correlated with disease severity and the progression of both motor and cognitive functions using an electrochemiluminescence immunoassay [33], while when the serum NF-L was measured by Simoa together with other fluid biomarkers, it helped to discriminate PD patients from controls [34].